7-7 | As of early July, 141 cases of COVID-19 have been confirmed in Cambodia. Roughly a quarter of these originated from a group of tourists who were travelling through the country in March when almost all of them got infected. When the first cases of COVID-19 were confirmed in Cambodia in March, the Médecins Sans Frontières/Doctors Without Borders (MSF) team had to quickly halt their regular hepatitis C activities to prevent patients from being infected with the virus during visits to the clinic.
5-4 | MSF teams around the world are responding to the COVID-19 pandemic, in both countries where we've previously worked, and those we haven't had to work in before. Here are our teams at work in pictures.Find out how we're responding to the COVID-19 crisis around the world.
7-24 | A simplified model of care for hepatitis C patients in Cambodia has shown outstanding results with 97% of patients cured from the disease in just three months, Médecins Sans Frontières (MSF) said. Since 2016, MSF has treated more than 13,000 patients in Cambodia’s capital, Phnom Penh, through a simpler and more affordable model of care, a crucial requirement to widen treatment access and eliminate hepatitis C in the country. Hepatitis C, a blood-borne virus that attacks the liver, is endemic in Cambodia.
6-4 | Arish was born in October 2018 at the MSF birthing unit in Chaman District Headquarter (DHQ) Hospital, Balochistan. He was discharged in good health. Just four days after his birth, however, he was back at the hospital in severe distress. His mother, Malaika, was unable to produce enough milk to feed him. “When I couldn’t feed him, I gave him green tea instead.
6-19 | Affordable generic versions from China could save millions of people’s lives Médecins Sans Frontières (MSF) today filed a legal patent challenge at China’s State Intellectual Property Office (SIPO), requesting the invalidation of the patent granted to US pharmaceutical corporation Gilead Sciences for the oral hepatitis C medicine velpatasvir.